Provexis Share Discussion Threads

[librag] 06/4/2017 12:29

Bernie, I think you're missing the point somewhat. See what I did there? :)

We need dietary supplement clinical evidence first to then justify pharmaceutical interest later on. Basically it's one step at a time. Frustrating to think we could have done the ground work years ago.

If PXS control future IP development, as we have with WSTC, it will justify a significant valuation in due course.

[senor_sensible] 06/4/2017 11:55

lol, By-health has been on my radar for a while, things work differently in China and the rumours can go for a while prior to decisions and agreements being made leading to news. of course I'm giddy, but then I have nice low average price showing profit ~;-)

[dil2211] 06/4/2017 11:55

Been predicted successful for outside the country.

[bareknee] 06/4/2017 11:42

Graham

It's good news, but By-Health ain't Pharma mate, they're dietary supplements so the BP work is likely to be an extension of what's already been done rather than the start of a pharma inspired piece of work

LOL@SS getting all giddy :)

Having said that, if the work with By-Health leads to something commercially viable, this might be the beginning of the end of PXS, but it's a long way off that at the moment.

BB

[senor_sensible] 06/4/2017 11:32

Re, AGL, I'm holding.......

[senor_sensible] 06/4/2017 11:31

Libra, I think this has more legs in it in short term, let's hope they fundraise or place share with By-Health at over 1p. I'm of the mind to keep share longer term though, direction and strategy of the company much more to my liking.

[librag] 06/4/2017 11:17

Some firms do placings to take advantage of spikes in the share price Let's see how bright our BoD is.

[librag] 06/4/2017 11:13

SS; nice and early'ish start for me today. :) Thoughts on AGL and FDI?

Personally, I think today's news is probably the best possible. It allays fears of significant fund raising for now yet gives hope of tangible pharmaceutical interest in due course.
There'll likely be a small fundraising soon but money for R&D will come, hopefully, once we're profitable.
Excellent news.

Thoughts RP and Bernie?

[senor_sensible] 06/4/2017 11:07

lol, By-health is a Chinese listed company, the news has been released on Chinese stock exchanges.

[lafin] 06/4/2017 11:01

Anyway I'm pleased share price seems to be going up.

[lafin] 06/4/2017 10:57

How do you know news is all over Shanghai and Shenzhen stock exchanges???
Have you taken leave of your senses?

[senor_sensible] 06/4/2017 10:34

This news is all over the shanghai and Shenzhen stock exchanges, lots of potential new investors learning about PXS. I am feeling much happier investing here.

[senor_sensible] 06/4/2017 10:24

Got money and know how to market and make a profit :-)

[senor_sensible] 06/4/2017 10:14

I would prefer placing to Myhealth, speaks volumes having a collaboration partner who has beneficial interest in your success and profitability. Would be even better if DSM upped their stake too. Don't under estimate the Chinese market, Probably more people with CVDblood pressure concerns in China, Who tend to look for natural remedies than the total population of Europe. This could be a game changer.

Defo good news and IMO a good source of newsflow for the next year of so. this will re-rate Upwards IMO.

[lafin] 06/4/2017 10:09

You are thinking takeover again SS.
That I do know.

[lafin] 06/4/2017 10:04

Don't know if that would be good or bad.

[senor_sensible] 06/4/2017 09:35

What are peeps thoughts on By Health becoming a major shareholder in PXS?

[davidlloyd] 06/4/2017 08:22

Now showing on leader board so will get more notice....
DL

[davidlloyd] 06/4/2017 08:06

Long time in auction.....
DL

[senor_sensible] 05/4/2017 11:26

Libra, AGL looking good for above 70p this year so selling early not an easy option and this looks like it is about to have another go at breaking out so difficult decisions :-) but nice problems to have for me.

[lafin] 04/4/2017 15:55

Wish it would just happen to get it out of the way.

[twodegrees] 04/4/2017 15:28

LAST PLACING WAS :

The New Provexis Shares have been issued at a gross 0.24p per share and rank pari passu in all respects with the existing ordinary shares of 0.1p each in Provexis.

The Placing represents a gross discount of 14.3 per cent to the closing mid-market price per Ordinary Share on 1 August 2016, being the latest practicable date prior to this announcement.

The Company's RNS announcement of 29 June 2016 confirmed that the Company then had non-legally binding indications of interest in a placing to raise a total of approximately GBP185,000 at a subscription price of 0.24 pence per ordinary share. The GBP185,000 interest announced on 29 June comprised indications of a GBP25,000 interest from the Company's Chairman Dawson Buck, with indications of a GBP160,000 interest from other investors.

Under the Company's code on dealings in securities the Company is now in a close period for directors' dealings which means that Dawson Buck will not be able to take up his subscription until the Company's audited annual report and accounts are published, expected in early September. Dawson Buck has therefore given a stated intention to subscribe to 10,416,667 shares at a subscription price of 0.24p totalling GBP25,000, with his formal commitment to and payment for the subscription to take effect in September immediately after publication of the Company's annual report and accounts.

The GBP224,000 Placing announced today with new and existing investors excludes Dawson Buck's stated intention to subscribe to 10,416,667 shares totalling GBP25,000 in September 2016, and it therefore represents a GBP64,000 increase over the GBP160,000 interest from other investors announced on 29 June. The total funds which are expected to be raised from the Placing announced today and from Dawson Buck's GBP25,000 intended share subscription in September 2016 amount to GBP249,000.


So maybe in hindsight 0.40 is too optimistic....